ID
MDCO

Integral Derivatives’s Medicines Co MDCO Stock Holding History

Integral Derivatives’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$428K Sell
13,000
-44,200
-77% -$1.38M 0.01% 424
2017
Q4 		$1.56M Buy
57,200
+11,700
+26% +$360K 0.03% 353
2017
Q3 		$1.69M Buy
45,500
+25,800
+131% +$951K 0.03% 355
2017
Q2 		$749K Buy
19,700
+15,500
+369% +$690K 0.02% 579
2017
Q1 		$205K Buy
+4,200
New +$192K ﹤0.01% 1016
2016
Q3 		– Sell
-6,500
Closed -$219K – 1214
2016
Q2 		$219K Buy
+6,500
New +$229K 0.01% 822

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Integral Derivatives's MDCO Position: Q1 2017 in Review

Integral Derivatives sold out of Medicines Co (MDCO) in Q1 2017, closing a stake of 21,025 shares — an estimated $959K sold.

Integral Derivatives first reported a position in MDCO in Q4 2016 and held it in 1 quarter. The position peaked at $714K in Q4 2016. 220 funds tracked by Wall St. Rank hold MDCO as of Q1 2017.

  • Integral Derivatives reported no remaining Medicines Co position as of Q1 2017 after selling out during the quarter.
  • Integral Derivatives sold 21,025 Medicines Co shares in Q1 2017, an estimated $959K.
  • Integral Derivatives first reported a position in Medicines Co in Q4 2016 and held it in 1 quarter.
  • Integral Derivatives's Medicines Co position peaked at $714K in Q4 2016.
  • 220 funds tracked by Wall St. Rank held Medicines Co as of Q1 2017.

Based on Integral Derivatives's 13F filing for Q1 2017, filed 15 May 2017.